Clinical Pharmacy Laboratory, Chinese PLA General Hospital, Beijing 100853, China.
Institute of Geriatrics, National Clinical Research Center of Geriatrics Disease, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Cytokine. 2021 Oct;146:155630. doi: 10.1016/j.cyto.2021.155630. Epub 2021 Jul 7.
Atherosclerosis-related cardiovascular diseases are the leading cause of mortality worldwide. Macrophage-derived foam cell formation is a critical early event in atherogenesis. However, the molecular pathways involved in this disease have not been fully elucidated. Interleukin (IL)-36 plays a crucial role in inflammation, and this study was conducted to investigate the possible role of IL-36γ in the pathogenesis and regulation of atherosclerosis. In this study, we show that IL-36γ regulates inflammatory responses and lipoprotein metabolic processes in macrophages and exerts its atherosclerosis-promoting effects by increasing macrophage foam cell formation and uptake of oxidized low-density lipoproteins. Mechanistically, IL-36γ specifically upregulates expression of the scavenger receptor CD36 through the phosphoinositide 3-kinase pathway in macrophages. These results contribute to our understanding of IL-36γ as a novel regulator of foam cell formation and atherogenesis progression.
动脉粥样硬化相关心血管疾病是全球范围内导致死亡的主要原因。巨噬细胞源性泡沫细胞的形成是动脉粥样硬化发生的一个关键早期事件。然而,该疾病涉及的分子途径尚未完全阐明。白细胞介素(IL)-36 在炎症中发挥着关键作用,本研究旨在探讨 IL-36γ 在动脉粥样硬化发病机制和调控中的可能作用。在这项研究中,我们表明 IL-36γ 通过调节巨噬细胞中的炎症反应和脂蛋白代谢过程,以及通过增加巨噬细胞泡沫细胞形成和氧化型低密度脂蛋白的摄取来发挥其促进动脉粥样硬化的作用。在机制上,IL-36γ 通过巨噬细胞中的磷酸肌醇 3-激酶途径特异性地上调清道夫受体 CD36 的表达。这些结果有助于我们理解 IL-36γ 作为泡沫细胞形成和动脉粥样硬化进展的新型调节剂。